Expand Box Expand Box Expand Box Close Close

We're standing by & we can help. It's free and confidential.*

Reach us now Chat Image

OR (800) 476-6070

*I agree that submitting this form does not create an attorney client relationship and that Weitz & Luxenberg will use the information I am providing to check for conflicts of interest to determine if the firm can assist me.

Weitz and Luxenburg logo 

Contact Us Home Page Image

Paul J. Pennock Practice Group Chair, Defective Drugs and Devices

  Get in touchGet in touch

Telephone: (212) 558-5500

Fax: (212) 344-5461

700 Broadway
New York, NY 10003


For two decades, Mr. Pennock has been chair of the Drug and Medical Device Litigation practice group at Weitz & Luxenberg.

He is directly responsible for leading a large national litigation department covering all aspects of litigation — from inception through trial. He has served as lead plaintiffs’ counsel, as well as plaintiff steering committee member, and liaison counsel in numerous state and federal multidistrict-litigation (MDL) mass tort cases.

This includes his current appointment as co-lead of the federal court Actos Multidistrict-Litigation coordination. In this role, he led the efforts in the recent $9 billion jury verdict, at the time the highest jury verdict in history for a personal injury case.  Mr. Pennock has also handled numerous bellwether trials and Daubert hearings on expert-witness testimony in both state and federal courts.

He was also named national co-lead counsel of the federal power morcellator MDL, where he organized the first majority women Plaintiff Steering Committee in the 47 year history of multidistrict litigation

As a well-respected member of the bar, he has been an invited speaker to dozens of legal conferences around the country, as well as at several law schools including Yale, Brooklyn, and the University of Denver, among others.

In 2007, he was honored with the invitation to author the mass tort litigation chapter in a two-volume legal treatise, “The Plaintiff’s Personal Injury Action in New York State” published by New York State Bar Association, edited by Patrick J. Higgins. It was published in 2009 and Mr. Pennock regularly provides updates. 

Every year since 2007 he has been designated a ”Super Lawyer.” He also has been a long-running ”Best Lawyers” honoree. The National Law Journal calls him one of  ”America’s Elite Trial Lawyers.”

Mr. Pennock is widely considered, by both sides of the bar, as one of the best and most aggressive plaintiff litigators in the country. His work has led to more than a billion dollars in recoveries for Weitz & Luxenberg clients.

Leadership Roles (Plaintiffs’ Steering Committees or Liaison Counsel)

  • Accutane Products Liability Litigation, MDL No. 1626
  • Actos Products Liability Litigation, MDL No. 2299, Co-Lead Counsel
  • Ethicon, Inc., Power Morcellator Products Liability Litigation, MDL No. 2652, Co-Lead Counsel
  • Depuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation, MDL No. 2244, Science Committee
  • Guidant Corp. Implantable Defibrillators Products Liability Litigation, MDL No. 1708
  • New York State ReNu with MoistureLoc Product Liability Litigation, Index No. 766,000/2007, Liaison Counsel
  • Seroquel Products Liability Litigation, MDL No. 1769, Co-Lead Counsel
  • Silcone Breast Implant Litigation, Index No.  500,000/1993, Liaison Counsel
  • Wright Hip System Cases, Judicial Council Coordination Proceeding (JCCP) No.  4710
  • Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2100
Speaking engagements
Associations & Licenses


  • J.D., St. John’s University, 1988
  • B.A., Syracuse University, 1984

Bar Admissions

  • 1989, New York
  • 1992, U.S. District Court, Southern District of New York
  • 1997, U.S. District Court, Eastern District of New York
  • 2003, United States Supreme Court
  • 2005, U.S. District Court, Western District of New York
  • 2011, U.S. District Court, Northern District of New York
  • 2014, United States Court of Appeals, 5th Circuit

Recent W&L Results

  • $1 Billion

    W&L's Ellen Relkin, as lead counsel in the NJ Rejuvenate and ABG II hip stem litigation, played a key role in negotiating the more than $1 billion settlement. Most qualifying plaintiffs will receive $300,000 or more.

  • $2.5 Billion

    W&L helped negotiate one of the largest mass tort settlements in recent history. More than 300 W&L clients are part of the settlement. Claimants had recalled DePuy ASR hips implanted and removed prior to August 31, 2013.

Free Case Evaluation